Möhlig M - Search Results

1

Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

Spranger J, Osterhoff M, Reimann M, Möhlig M, Ristow M, Francis MK, Cristofalo V, Hammes HP, Smith G, Boulton M, Pfeiffer AF. Spranger J, et al. Among authors: mohlig m. Diabetes. 2001 Dec;50(12):2641-5. doi: 10.2337/diabetes.50.12.2641. Diabetes. 2001. PMID: 11723044

2

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Spranger J, et al. Among authors: mohlig m. Diabetes. 2003 Mar;52(3):812-7. doi: 10.2337/diabetes.52.3.812. Diabetes. 2003. PMID: 12606524

3

Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.

Mai K, Andres J, Biedasek K, Weicht J, Bobbert T, Sabath M, Meinus S, Reinecke F, Möhlig M, Weickert MO, Clemenz M, Pfeiffer AF, Kintscher U, Spuler S, Spranger J. Mai K, et al. Among authors: mohlig m. Diabetes. 2009 Jul;58(7):1532-8. doi: 10.2337/db08-1775. Epub 2009 Apr 28. Diabetes. 2009. PMID: 19401423 Free PMC article.

4

Insulin decreases human adiponectin plasma levels.

Möhlig M, Wegewitz U, Osterhoff M, Isken F, Ristow M, Pfeiffer AF, Spranger J. Möhlig M, et al. Horm Metab Res. 2002 Nov-Dec;34(11-12):655-8. doi: 10.1055/s-2002-38248. Horm Metab Res. 2002. PMID: 12660877 Clinical Trial.

5

Levothyroxine medication is associated with adiposity independent of TSH.

Ruhla S, Arafat AM, Osterhoff M, Weickert MO, Mai K, Spranger J, Schöfl C, Pfeiffer AF, Möhlig M. Ruhla S, et al. Among authors: mohlig m. Exp Clin Endocrinol Diabetes. 2012 Jun;120(6):351-4. doi: 10.1055/s-0032-1312599. Epub 2012 May 25. Exp Clin Endocrinol Diabetes. 2012. PMID: 22639395

6

Effect of meglitinides on postprandial ghrelin secretion pattern in type 2 diabetes mellitus.

Rudovich N, Möhlig M, Otto B, Pivovarova O, Spranger J, Weickert MO, Pfeiffer AF. Rudovich N, et al. Among authors: mohlig m. Diabetes Technol Ther. 2010 Jan;12(1):57-64. doi: 10.1089/dia.2009.0129. Diabetes Technol Ther. 2010. PMID: 20082586 Clinical Trial.

7

Hepatic insulin clearance is closely related to metabolic syndrome components.

Pivovarova O, Bernigau W, Bobbert T, Isken F, Möhlig M, Spranger J, Weickert MO, Osterhoff M, Pfeiffer AF, Rudovich N. Pivovarova O, et al. Among authors: mohlig m. Diabetes Care. 2013 Nov;36(11):3779-85. doi: 10.2337/dc12-1203. Epub 2013 Sep 11. Diabetes Care. 2013. PMID: 24026549 Free PMC article.

8

Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?

Spranger J, Möhlig M, Osterhoff M, Bühnen J, Blum WF, Pfeiffer AF. Spranger J, et al. Among authors: mohlig m. Horm Metab Res. 2001 May;33(5):312-6. doi: 10.1055/s-2001-15283. Horm Metab Res. 2001. PMID: 11440279

9

Post-prandial decrease of human plasma ghrelin in the absence of insulin.

Spranger J, Ristow M, Otto B, Heldwein W, Tschöp M, Pfeiffer AF, Möhlig M. Spranger J, et al. Among authors: mohlig m. J Endocrinol Invest. 2003 Aug;26(8):RC19-22. doi: 10.1007/BF03347349. J Endocrinol Invest. 2003. PMID: 14669821

10

Adiponectin and protection against type 2 diabetes mellitus.

Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Spranger J, et al. Among authors: mohlig m. Lancet. 2003 Jan 18;361(9353):226-8. doi: 10.1016/S0140-6736(03)12255-6. Lancet. 2003. PMID: 12547549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page